"10.1371_journal.pone.0077155","plos one","2013-10-10T00:00:00Z","Uwe Rix; Jacques Colinge; Katharina Blatt; Manuela Gridling; Lily L Remsing Rix; Katja Parapatics; Sabine Cerny-Reiterer; Thomas R Burkard; Ulrich JÃ¤ger; Junia V Melo; Keiryn L Bennett; Peter Valent; Giulio Superti-Furga","CeMM â€ Research Center, Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria; Ludwig Boltzmann Cluster Oncology, Vienna, Austria; Department of Haematology, Centre for Cancer Biology, Adelaide, Australia; Imperial College London, London, United Kingdom","Conceived and designed the experiments: UR JC KB KLB PV GSF UJ. Performed the experiments: UR KB MG LLRR KP SCR. Analyzed the data: UR JC TRB. Contributed reagents/materials/analysis tools: JVM. Wrote the manuscript: UR JC JVM KLB PV GSF UJ.","We have the following competing interests: Bosutinib was a kind gift of Oridis Biomed. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","10","Uwe Rix","UR",13,TRUE,7,6,3,7,TRUE,TRUE,FALSE,0,NA,FALSE
